Restatement (Unaudited)

12 Months Ended

Dec. 31, 2021

Accounting Changes and Error Corrections [Abstract]

Restatement (Unaudited)

Restatement (Unaudited)

Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements

During the preparation of the consolidated financial statements as of and for the year ended December 31, 2021, the Company identified errors in the accounting for certain contracts under ASC 606. Specifically, certain contracts were inappropriately combined with other contracts and ITC related contracts were determined to have multiple performance obligations satisfied at a point in time instead of one performance obligation satisfied over time. The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate the quarterly unaudited condensed consolidated financial statements for the quarterly periods ended March 31, 2021, June 30, 2021 and September 30, 2021.

The following presents the restated quarterly unaudited financial statements as of March 31, 2021, June 30, 2021 and September 30, 2021, as well as the statements for the three month period ended March 31, 2021, the three and six month periods ended June 30, 2021 and the three and nine month periods ended September 30, 2021.

	March 31, 2021
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	19,133			$	19,133
Accounts receivable, net	121,921		2,308		124,229
Inventories, net	124,705				124,705
Income tax receivables	4,155				4,155
Prepaid expenses and other	15,639				15,639
Total current assets	285,553		2,308		287,861
Property, plant and equipment, net	9,740				9,740
Goodwill	69,727				69,727
Other intangible assets, net	192,383				192,383
Other assets	25,873				25,873
Total assets	$	583,276	$	2,308	$	585,584
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	71,823			$	71,823
Accounts payable - related party	2,608				2,608
Accrued expenses and other	34,551				34,551
Accrued warranty reserve	3,098				3,098
Income tax payable	10,224		657		10,881
Deferred revenue	89,880				89,880
Current portion of contingent consideration	9,567				9,567
Current portion of term loan	4,300				4,300
Other current liabilities	6,288				6,288
Total current liabilities	232,339		657		232,996
Long-term liabilities
Deferred tax liability	13,043		(38)		13,005
Contingent consideration, net of current portion	10,272				10,272
Other long-term liabilities	6,055				6,055
Long-term debt, net of current portion, debt discount and issuance costs	391,682				391,682
Total long-term liabilities	421,052		(38)		421,014
Total liabilities	653,391		619		654,010
Commitments and contingencies (Note 12)
Preferred stock of 0.001 par value - 5,000,000 shares authorized; none issued as of March 31, 2021	—				—

Common stock of $0.001 par value - 1,000,000,000 shares authorized; 126,994,467 shares issued as of March 31, 2021	127				127
Additional paid-in capital	148,370				148,370
Accumulated deficit	(218,612)		1,689		(216,923)
Total stockholders’ deficit	(70,115)		1,689		(68,426)
Total liabilities and stockholders’ deficit	$	583,276	$	2,308	$	585,584

	June 30, 2021
	As Previously Reported		Restatement Adjustments		As Reported
ASSETS
Current assets
Cash and cash equivalents	$	17,682			$	17,682
Accounts receivable, net	153,610		(3,972)		149,638
Inventories, net	137,666				137,666
Income tax receivables	9,657		(1,735)		7,922
Prepaid expenses and other	11,597				11,597
Total current assets	330,212		(5,707)		324,505
Property, plant and equipment, net	9,763				9,763
Goodwill	69,727				69,727
Other intangible assets, net	186,507				186,507
Other assets	26,109				26,109
Total assets	$	622,318	$	(5,707)	$	616,611
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	81,377			81,377
Accounts payable - related party	610				610
Accrued expenses and other	19,129				19,129
Accrued warranty reserve	2,968				2,968
Income tax payable	—				—
Deferred revenue	51,458				51,458
Current portion of contingent consideration	1,908				1,908
Current portion of term loan	4,300				4,300
Other current liabilities	6,379				6,379
Total current liabilities	168,129		—		168,129
Long-term liabilities
Deferred tax liability	14,472		(1,896)		12,576

Contingent consideration, net of current portion	10,108				10,108
Other long-term liabilities	4,273				4,273
Long-term debt, net of current portion, debt discount and issuance costs	493,945				493,945
Total long-term liabilities	522,798		(1,896)		520,902
Total liabilities	690,927		(1,896)		689,031
Commitments and contingencies (Note 12)
Preferred stock of 0.001 par value - 5,000,000 shares authorized; none issued as of June 30, 2021	—				—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 126,994,467 shares issued as of June 30, 2021	127				127
Additional paid-in capital	149,893				149,893
Accumulated deficit	(218,629)		(3,811)		(222,440)
Total stockholders’ deficit	(68,609)		(3,811)		(72,420)
Total liabilities and stockholders’ deficit	$	622,318	$	(5,707)	$	616,611

	September 30, 2021
	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	116,391			$	116,391
Restricted cash	—				—
Accounts receivable, net	177,462		(7,354)		170,108
Inventories, net	173,126				173,126
Income tax receivables	6,453		1,029		7,482
Prepaid expenses and other	18,193				18,193
Total current assets	491,625		(6,325)		485,300
Property, plant and equipment, net	10,202				10,202
Goodwill	69,727				69,727
Other intangible assets, net	180,630				180,630
Other assets	24,405				24,405
Total assets	$	776,589	$	(6,325)	$	770,264
LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)
Current Liabilities
Accounts payable	$	84,703			84,703
Accounts payable - related party	610				610

Accrued expenses and other	31,256				31,256
Accrued warranty reserve	3,025				3,025
Income tax payable	629				629
Deferred revenue	81,347				81,347
Current portion of contingent consideration	2,168				2,168
	—				—
Current portion of term loan	4,300				4,300
Other current liabilities	6,457				6,457
Total current liabilities	214,495		—		214,495
Long-term liabilities
Deferred tax liability	6,583		(505)		6,078
Contingent consideration, net of current portion	10,784				10,784
Other long-term liabilities	2,953				2,953
Long-term debt, net of current portion, debt discount and issuance costs	299,212				299,212
Total long-term liabilities	319,532		(505)		319,027
Total liabilities	534,027		(505)		533,522
Commitments and contingencies (Note 13)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 350,000 issued as of September 30, 2021; liquidation preference of $352.8 million at September 30, 2021	235,278				235,278
Stockholders’ equity/(deficit)					—
Preferred stock of $0.001 par value - 4,500,000 shares authorized; zero issued as of September 30, 2021	—				—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 134,869,467 shares issued as of September 30, 2021	135				135
Additional paid-in capital	251,330				251,330
Accumulated deficit	(244,181)		(5,820)		(250,001)
Total stockholders’ equity/(deficit)	7,284		(5,820)		1,464
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity/(deficit)	$	776,589	$	(6,325)	$	770,264

	Three Months Ended March 31, 2021
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	245,932		$	2,308	$	248,240
Cost of revenue	202,074				202,074
Gross profit	43,858		2,308		46,166
Operating expenses
General and administrative	24,673				24,673
Contingent consideration	148				148
Depreciation and amortization	5,984				5,984
Total operating expenses	30,805		—		30,805
Income from operations	13,053		2,308		15,361
Other expense
Other expense, net	(78)				(78)
Interest expense	(9,009)				(9,009)
Total other expense	(9,087)		—		(9,087)
Income before income tax expense	3,966		2,308		6,274
Income tax expense	1,079		619		1,698
Net income	$	2,887	$	1,689	$	4,576
Earnings per share
Basic	$	0.02	$	0.01	$	0.04
Diluted	$	0.02	$	0.01	$	0.04
Weighted average number of shares
Basic	126,994		126,994		126,994
Diluted	127,298		127,298		127,298

	Three Months Ended June 30, 2021
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	202,796		$	(6,280)	$	196,516
Cost of revenue	176,009				176,009
Gross profit	26,787		(6,280)		20,507
Operating expenses
General and administrative	15,113				15,113
Contingent consideration	(13)				(13)
Depreciation and amortization	5,981				5,981
Total operating expenses	21,081		—		21,081
Income (loss) from operations	5,706		(6,280)		(574)
Other expense
Other expense, net	(122)				(122)
Interest expense	(6,651)				(6,651)
Total other expense	(6,773)		—		(6,773)
Loss before income tax expense	(1,067)		(6,280)		(7,347)
Income tax benefit	(1,050)		(780)		(1,830)
Net loss	$	(17)	$	(5,500)	$	(5,517)
Loss per share
Basic	$	—	$	(0.04)	$	(0.04)
Diluted	$	—	$	(0.04)	$	(0.04)
Weighted average number of shares
Basic	126,994		126,994		126,994
Diluted	126,994		126,994		126,994

	Three Months Ended September 30, 2021
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	192,068	$	(3,382)	$	188,686
Cost of revenue	182,789				182,789
Gross profit	9,279		(3,382)		5,897
Operating expenses
General and administrative	18,493				18,493
Contingent consideration	936				936
Depreciation and amortization	5,984				5,984
Total operating expenses	25,413		—		25,413
Loss from operations	(16,134)		(3,382)		(19,516)
Other expense
Other expense, net	(297)				(297)
Interest expense	(13,109)				(13,109)
Total other expense	(13,406)		—		(13,406)
Loss before income tax benefit	(29,540)		(3,382)		(32,922)
Income tax benefit	(3,988)		(1,373)		(5,361)
Net loss	$	(25,552)	$	(2,009)	$	(27,561)
Preferred dividends and accretion	(5,479)				(5,479)
Net loss to common shareholders	$	(31,031)	$	(2,009)	$	(33,040)
Loss per share
Basic	$	(0.24)	$	(0.02)	$	(0.25)
Diluted	$	(0.24)	$	(0.02)	$	(0.25)
Weighted average number of shares
Basic	130,955		130,955		130,955
Diluted	130,955		130,955		130,955

	Six Months Ended June 30, 2021
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	448,728	$	(3,972)	$	444,756
Cost of revenue	378,083				378,083
Gross profit	70,645		(3,972)		66,673
Operating expenses
General and administrative	39,786				39,786
Contingent consideration	135				135
Depreciation and amortization	11,965				11,965
Total operating expenses	51,886		—		51,886
Income (loss) from operations	18,759		(3,972)		14,787
Other expense
Other expense, net	(200)				(200)
Interest expense	(15,660)				(15,660)
Total other expense	(15,860)		—		(15,860)
Income (loss) before income tax expense	2,899		(3,972)		(1,073)
Income tax expense (benefit)	29		(161)		(132)
Net income (loss)	$	2,870	$	(3,811)	$	(941)
Earnings (loss) per share
Basic	$	0.02	$	(0.03)	$	(0.01)
Diluted	$	0.02	$	(0.03)	$	(0.01)
Weighted average number of shares
Basic	126,994		126,994		126,994
Diluted	127,203		127,203		127,203

	Nine Months Ended September 30,
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	640,796	$	(7,354)	$	633,442
Cost of revenue	560,872				560,872
Gross profit	79,924		(7,354)		72,570
Operating expenses
General and administrative	58,279				58,279
Contingent consideration	1,071				1,071
Depreciation and amortization	17,949				17,949
Total operating expenses	77,299		—		77,299
Income (loss) from operations	2,625		(7,354)		(4,729)
Other expense
Other expense, net	(497)				(497)
Interest expense	(28,769)				(28,769)
Total other expense	(29,266)		—		(29,266)
Loss before income tax benefit	(26,641)		(7,354)		(33,995)
Income tax benefit	(3,959)		(1,534)		(5,493)
Net loss	$	(22,682)	$	(5,820)	$	(28,502)
Preferred dividends and accretion	(5,479)				(5,479)
Net loss to common shareholders	$	(28,161)	$	(5,820)	$	(33,981)
Loss per share
Basic	$	(0.22)	$	(0.05)	$	(0.26)
Diluted	$	(0.22)	$	(0.05)	$	(0.26)
Weighted average number of shares
Basic	128,315		128,315		128,315
Diluted	128,315		128,315		128,315

Statement of Changes in Shareholders' Deficit- Three Months Ended March 31, 2021

(in thousands, share amounts) (unaudited)	Preferred Stock			Common Stock			Additional
As Previously Reported	Shares	Amount		Shares	Amount		paid-in capital		Retained earnings		Total Stockholders’ Deficit
Balance, December 31, 2020	—	$	—	126,994	$	127	$	140,473	$	(221,499)	$	(80,899)
Equity based compensation	—	—		—	—		7,897		—		7,897
Net Income	—	—		—	—		—		2,887		2,887
Balance, March 31, 2021	—	$	—	126,994	$	127	$	148,370	$	(218,612)	$	(70,115)
Adjustments
Balance, December 31, 2020	—	$	—	—	$	—	$	—	$	—	—
Net Income	—	—		—	—		—		1,689		1,689
Total Adjustments	—	$	—	—	$	—	$	—	$	1,689	1,689
As Restated
Balance, December 31, 2020	—	$	—	126,994	$	127	$	140,473	$	(221,499)	$	(80,899)
Equity based compensation	—	—		—	—		7,897		—		7,897
Net Income	—	—		—	—		—		4,576		4,576
Balance, March 31, 2021 - As Restated	—	—		126,994	$	127	$	148,370	$	(216,923)	$	(68,426)

Statement of Changes in Shareholders' Deficit- Three Months Ended June 30, 2021

(in thousands, share amounts) (unaudited)	Preferred Stock			Common Stock			Additional
As Previously Reported	Shares	Amount		Shares	Amount		paid-in capital		Retained earnings		Total Stockholders’ Deficit
Balance, March 31, 2021	—	$	—	126,994	127		148,370		(218,612)		$	(70,115)
Equity-based compensation	—	—		—	—		1,523		—		1,523
Net loss	—	—		—	—		—		(17)		(17)
Balance, June 30, 2021	—	$	—	126,994	$	127	$	149,893	$	(218,629)	$	(68,609)
Adjustments
Balance, March 31, 2021	—	$	—	—	$	—	$	—	$	1,689	1,689
Net loss	—	—		—	—		—		(5,500)		(5,500)
Total Adjustments	—	$	—	—	$	—	$	—	$	(3,811)	(3,811)
As Restated
Balance, March 31, 2021	—	$	—	126,994	$	127	$	148,370	$	(216,923)	$	(68,426)
Equity based compensation	—	—		—	—		1,523		—		1,523
Net loss	—	—		—	—		—		(5,517)		(5,517)
Balance, June 30, 2021 - As Restated	—	—		126,994	$	127	$	149,893	$	(222,440)	$	(72,420)

Statement of Changes in Shareholders' Equity/(Deficit) - Three Months Ended September 30, 2021

	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock			Additional
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		paid-in capital		Retained earnings		Total Stockholders’ Deficit
Balance, June 30, 2021	—	$	—	—	$	—	126,994	127		149,893		(218,629)		$	(68,609)
Equity-based compensation	—	—		—	—		—	—		2,160		—		2,160
Issuance of Series A Preferred, net of fees	350	229,799		—	—		—	—		—		—		—
Issuance of common stock, net	—	—		—	—		7,875	8		104,756		—		104,764
Preferred cumulative dividends plus accretion	—	5,479		—	—		—	—		(5,479)		—		(5,479)
Net loss	—	—		—	—		—	—		—		(25,552)		(25,552)
Balance, September 30, 2021	350	235,278		—	$	—	134,869	$	135	$	251,330	$	(244,181)	$	7,284
Adjustments
Balance, June 30, 2021	—	—		—	$	—	—	$	—	$	—	$	(3,811)	(3,811)
Net loss	—	—		—	—		—	—		—		(2,009)		(2,009)
Total Adjustments	—	—		—	$	—	—	$	—	$	—	$	(5,820)	(5,820)
As Restated
Balance, June 30, 2021	—	—		—	$	—	126,994	$	127	$	149,893	$	(222,440)	$	(72,420)
Equity based compensation	—	—		—	—		—	—		2,160		—		2,160

Issuance of Series A Preferred, net of fees	350	229,799	—	—	—	—		—		—		—
Issuance of common stock, net	—	—	—	—	7,875	8		104,756		—		104,764
Preferred cumulative dividends plus accretion	—	5,479	—	—	—	—		(5,479)		—		(5,479)
Net loss	—	—	—	—	—	—		—		(27,561)		(27,561)
Balance, September 30, 2021 - As Restated	350	235,278	—	—	134,869	$	—	$	251,330	$	(250,001)	$	1,464

Statement of Changes in Shareholders' Deficit- Six Months Ended June 30, 2021

(in thousands, share amounts) (unaudited)	Preferred Stock			Common Stock			Additional
As Previously Reported	Shares	Amount		Shares	Amount		paid-in capital		Retained earnings		Total Stockholders’ Deficit
Balance, December 31, 2020	—	$	—	126,994	$	127	$	140,473	$	(221,499)	$	(80,899)
Equity-based compensation	—	—		—	—		9,420		—		9,420
Net loss	—	—		—	—		—		2,870		2,870
Balance, June 30, 2021	—	$	—	126,994	$	127	$	149,893	$	(218,629)	$	(68,609)
Adjustments
Balance, December 31, 2020	—	$	—	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—		(3,811)		(3,811)
Total Adjustments	—	$	—	—	$	—	$	—	$	(3,811)	$	(3,811)
As Restated
Balance, December 31, 2020	—	$	—	126,994	$	127	$	140,473	$	(221,499)	$	(80,899)
Equity based compensation	—	—		—	—		9,420		—		9,420
Net loss	—	—		—	—		—		(941)		(941)
Balance, June 30, 2021 - As Restated	—	—		126,994	$	127	$	149,893	$	(222,440)	$	(72,420)

Statement of Changes in Shareholders' Equity/(Deficit) - Nine Months Ended September 30, 2021

	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock			Additional
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		paid-in capital		Retained earnings		Total Stockholders’ Deficit
Balance, December 31, 2020	—	$	—	—	$	—	126,994	127		140,473		$	(221,499)	$	(80,899)
Equity-based compensation	—	—		—	—		—	—		11,580		—		11,580
Issuance of Series A Preferred, net of fees	350	229,799		—	—		—	—		—		—		—
Issuance of common stock, net	—	—		—	—		7,875	8		104,756		—		104,764
Preferred cumulative dividends plus accretion	—	5,479		—	—		—	—		(5,479)		—		(5,479)
Net loss	—	—		—	—		—	—		—		(22,682)		(22,682)
Balance, September 30, 2021	350	235,278		—	$	—	134,869	$	135	$	251,330	$	(244,181)	$	7,284
Adjustments
Balance, December 31, 2020	—	—		—	$	—	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(5,820)		(5,820)
Total Adjustments	—	—		—	$	—	—	$	—	$	—	$	(5,820)	$	(5,820)
As Restated
Balance, December 31, 2020	—	—		—	$	—	126,994	$	127	$	140,473	$	(221,499)	$	(80,899)

Equity based compensation	—	—	—	—	—	—		11,580		—				11,580
Issuance of Series A Preferred, net of fees	350	229,799	—	—	—	—		—		—				—
Issuance of common stock, net	—	—	—	—	7,875	8		104,756		—				104,764
Preferred cumulative dividends plus accretion	—	5,479	—	—	—	—		(5,479)		—				(5,479)
Net loss	—	—	—	—	—	—		—		(28,502)				(28,502)
Balance, September 30, 2021 - As Restated	350	235,278	—	—	134,869	$	—	$	251,330	$	(250,001)	$	—	$	1,464

	Three Months Ended March 31, 2021
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows used in operating activities
Net income	$	2,887	$	1,689	$	4,576
Adjustments to reconcile net income to net cash used in operating activities:
Recovery of bad debts	(535)				(535)
Deferred tax benefit	(71)		(38)		(109)
Depreciation and amortization	6,481				6,481
Amortization of debt discount and issuance costs	3,586				3,586
Interest paid-in-kind	—				—
Equity-based compensation	7,911				7,911
Contingent consideration	148				148
Warranty provision	302				302
Changes in operating assets and liabilities					—
Accounts receivable	(2,692)		(2,308)		(5,000)
Inventories	(6,246)				(6,246)
Income tax receivables	13,003				13,003
Prepaid expenses and other	(3,216)				(3,216)
Accounts payable	(10,556)				(10,556)
Accounts payable - related party	—				—
Accrued expenses and other	5,134				5,134
Income tax payable	1,410		657		2,067
Lease liabilities	247				247
Deferred revenue	(59,941)		—		(59,941)
Net cash used in operating activities	(42,148)		—		(42,148)
Cash flows used in investing activities
Purchase of property, plant and equipment	(570)				(570)
Investment in equity security	(10,000)				(10,000)
Net cash used in investing activities	(10,570)		—		(10,570)
Cash flows used in financing activities
Proceeds from revolving credit facility	—
Principal payments on term loan facility	(30,000)				(30,000)
Debt issuance costs	(6,590)				(6,590)
Net cash used in financing activities	(36,590)		—		(36,590)
Net decrease in cash, cash equivalents and restricted cash	(89,308)		—		(89,308)
Cash, cash equivalents and restricted cash, beginning of period	108,441				108,441
Cash, cash equivalents, and restricted cash, end of period	$	19,133	$	—	$	19,133

\

Statement of Cash Flows
	Six Months Ended June 30,
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows used in operating activities
Net income	$	2,870	$	(3,811)	$	(941)
Adjustments to reconcile net income to net cash used in operating activities:
Recovery of bad debts	(551)				(551)
Deferred tax benefit	1,358		(1,896)		(538)
Depreciation and amortization	12,964				12,964
Amortization of debt discount and issuance costs	5,118				5,118
Interest paid-in-kind	—				—
Equity-based compensation	9,467				9,467
Contingent consideration	135				135
Warranty provision	425				425
Provision for inventory obsolescence	1,236				1,236
Changes in operating assets and liabilities					—
Accounts receivable	(34,365)		3,972		(30,393)
Inventories	(20,443)				(20,443)
Income tax receivables	7,501		1,735		9,236
Prepaid expenses and other	826				826
Accounts payable	(1,378)				(1,378)
Accounts payable - related party	(1,622)				(1,622)
Accrued expenses and other	(10,541)				(10,541)
Income tax payable	(8,814)				(8,814)
Lease liabilities	68				68
Deferred revenue	(98,363)		—		(98,363)
Net cash used in operating activities	(134,109)		—		(134,109)
Cash flows used in investing activities
Purchase of property, plant and equipment	(1,200)				(1,200)
Investment in equity security	(11,975)		—		(11,975)
Net cash used in investing activities	(13,175)		—		(13,175)
Cash flows from financing activities
Proceeds from revolving credit facility	102,000				102,000
Principal payments on term loan facility	(31,075)				(31,075)
Payments on related party loans	—				—
Contingent consideration	(7,810)		—		(7,810)
Debt issuance costs	(6,590)		—		(6,590)
Net cash provided by financing activities	56,525		—		56,525
Net decrease in cash, cash equivalents and restricted cash	(90,759)		—		(90,759)

Cash, cash equivalents and restricted cash, beginning of period	108,441				108,441
Cash, cash equivalents, and restricted cash, end of period	$	17,682	$	—	$	17,682

Statement of Cash Flows

	Nine Months Ended September 30,
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows used in operating activities
Net loss	$	(22,682)	$	(5,820)	$	(28,502)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Recovery of bad debts	(574)				(574)
Deferred tax benefit	(6,531)		(505)		(7,036)
Depreciation and amortization	19,454				19,454
Amortization of debt discount and issuance costs	13,653				13,653
Interest paid-in-kind	—				—
Equity-based compensation	11,706				11,706
Contingent consideration	1,071				1,071
Warranty provision	305				305
Provision for inventory obsolescence	654				654
Changes in operating assets and liabilities					—
Accounts receivable	(58,194)		7,354		(50,840)
Inventories	(55,321)				(55,321)
Income tax receivables	10,705		(1,029)		9,676
Prepaid expenses and other	(5,770)				(5,770)
Accounts payable	1,948				1,948
Accounts payable - related party	(1,622)				(1,622)
Accrued expenses and other	1,683				1,683
Income tax payable	(8,185)				(8,185)
Lease liabilities	337				337
Deferred revenue	(68,474)		—		(68,474)
Net cash used in operating activities	(165,837)		—		(165,837)
Cash flows used in investing activities
Purchase of property, plant and equipment	(2,252)				(2,252)
Investment in equity security	(11,975)				(11,975)
Net cash used in investing activities	(14,227)		—		(14,227)
Cash flows from financing activities
Proceeds from revolving credit facility	102,000				102,000
Principal payments on term loan facility	(132,150)				(132,150)
Proceeds from Series A issuance	224,987				224,987
Proceeds from common stock issuance	120,645				120,645
Series A equity issuance costs	(7,195)				(7,195)

Common stock issuance costs	(3,873)				(3,873)
Payments on revolving credit facility	(102,000)				(102,000)
Payments on related party loans	—				—
Contingent consideration	(7,810)				(7,810)
Deferred offering costs	—				—
Debt issuance costs	(6,590)		—		(6,590)
Net cash provided by financing activities	188,014		—		188,014
Net change in cash and cash equivalents	7,950		—		7,950
Cash and cash equivalents, beginning of period	108,441				108,441
Cash and cash equivalents, end of period	$	116,391	$	—	$	116,391